{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:04:58Z","timestamp":1779433498055,"version":"3.53.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Huikang Renai Foundation Project","award":["BHCFRF-20250520-28"],"award-info":[{"award-number":["BHCFRF-20250520-28"]}]},{"name":"Anhui Chest Hospital Project","award":["AHXK20251005"],"award-info":[{"award-number":["AHXK20251005"]}]},{"name":"Anhui Chest Hospital Project","award":["AHXK20251004"],"award-info":[{"award-number":["AHXK20251004"]}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Immune checkpoint inhibitors (ICIs) have improved survival in extensive-stage small-cell lung cancer (SCLC) but may cause checkpoint inhibitor pneumonitis (CIP). Management of CIP often requires prolonged high-dose corticosteroids, leading to profound immunosuppression and increased risk of opportunistic infections. Among these,\n                      <jats:italic>Pneumocystis jirovecii<\/jats:italic>\n                      pneumonia (PJP) is a life-threatening complication in non-HIV patients and carries higher mortality than HIV-associated PJP. Early etiological diagnosis is therefore essential. We report a case of severe PJP diagnosed by metagenomic next-generation sequencing (mNGS) and successfully managed with comprehensive respiratory support.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 69-year-old HIV-negative man with extensive-stage SCLC received four cycles of etoposide-platinum chemotherapy plus adebrelimab. Subsequently, CIP developed and required prolonged high-dose methylprednisolone therapy. He was transferred to our hospital for progressive dyspnea. Evaluation showed severe hypoxemia (PaO\u2082\/FiO\u2082 185\u202fmmHg) and markedly elevated serum 1,3-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      -D-glucan (3327.99\u202fpg.\/mL). Bronchoalveolar lavage fluid mNGS identified\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      as the predominant pathogen, with\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      ,\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      , and\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      indicating mixed pulmonary infection. The patient received trimethoprim-sulfamethoxazole, cefoperazone-sulbactam, and caspofungin. Worsening respiratory failure required endotracheal intubation and mechanical ventilation. Lung recruitment maneuvers, individualized positive end-expiratory pressure titration, and adjunctive inhaled nitric oxide progressively improved oxygenation, allowing successful extubation and eventual discharge.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Severe PJP should be considered in non-HIV patients receiving corticosteroids for CIP. mNGS enabled rapid pathogen identification and targeted therapy. Comprehensive respiratory support, including optimized mechanical ventilation and inhaled nitric oxide, may be valuable in managing life-threatening opportunistic infections in immunosuppressed patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1808578","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:08:40Z","timestamp":1779430120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful management of severe Pneumocystis jirovecii pneumonia with inhaled nitric oxide and individualized ventilatory strategies in an immunosuppressed patient: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Haobo","family":"Kong","sequence":"first","affiliation":[{"name":"Department of Respiratory Intensive Care Unit, Anhui Chest Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Respiratory Intensive Care Unit, Anhui Chest Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Anhui Chest Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Anhui Chest Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[{"name":"Operating Room of Anhui Chest Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Anhui Chest Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Anhui Chest Hospital","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1200\/JCO.2016.68.2005","article-title":"Pneumonitis in patients treated with anti-programmed Death-1\/programmed death ligand 1 therapy","volume":"35","author":"Naidoo","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.6004\/jnccn.2022.7020","article-title":"The risk of opportunistic infections and the role of antibiotic prophylaxis in patients on checkpoint inhibitors requiring steroids","volume":"20","author":"Shah","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.chest.2024.01.015","article-title":"Characteristics and prognosis factors of pneumocystis jirovecii pneumonia according to underlying disease: a retrospective multicenter study","volume":"165","author":"Lecuyer","year":"2024","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1129730","DOI":"10.3389\/fphar.2023.1129730","article-title":"Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: a systematic literature review of published case reports and disproportionality analysis based on the FAERS database","volume":"14","author":"Xia","year":"2023","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3201\/eid2608.191493","article-title":"Analysis of MarketScan data for immunosuppressive conditions and hospitalizations for acute respiratory illness, United States","volume":"26","author":"Patel","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e037419","DOI":"10.1136\/bmjopen-2020-037419","article-title":"Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study","volume":"10","author":"Li","year":"2020","journal-title":"BMJ Open"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.chest.2025.10.036","article-title":"Adjunctive corticosteroid use and clinical outcomes in non-HIV pneumocystis jirovecii pneumonia","volume":"169","author":"Pulsipher","year":"2025","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S2213-2600(25)00125-0","article-title":"Adjunctive corticosteroids in non-AIDS patients with severe pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial","volume":"13","author":"Lemiale","year":"2025","journal-title":"Lancet Respir Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13613-024-01337-8","article-title":"Interpretation of results of PCR and B-D-glucan for the diagnosis of pneumocystis Jirovecii pneumonia in immunocompromised adults with acute respiratory failure","volume":"14","author":"Calvet","year":"2024","journal-title":"Ann Intensive Care"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11046-024-00849-y","article-title":"Rapid diagnosis of pneumocystis jirovecii pneumonia and respiratory tract colonization by next-generation sequencing","volume":"189","author":"Xing","year":"2024","journal-title":"Mycopathologia"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0010122","DOI":"10.1128\/jcm.00101-22","article-title":"Accuracy of pneumocystis jirovecii plasma cell-free DNA PCR for noninvasive diagnosis of pneumocystis pneumonia","volume":"60","author":"Moreno","year":"2022","journal-title":"J Clin Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"812005","DOI":"10.3389\/fmed.2022.812005","article-title":"Pneumocystis Jirovecii pneumonia diagnosis via metagenomic next-generation sequencing","volume":"9","author":"Lu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"812698","DOI":"10.3389\/fmed.2022.812698","article-title":"Characteristics and prognostic factors of non-HIV immunocompromised patients with pneumocystis pneumonia diagnosed by metagenomics next-generation sequencing","volume":"9","author":"Duan","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s13054-023-04608-1","article-title":"Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG","volume":"27","author":"Giacobbe","year":"2023","journal-title":"Crit Care"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"8904","DOI":"10.21037\/jtd-2025-499","article-title":"Clinical characteristics of pneumocystis jirovecii pneumonia in 20 non-HIV-infected patients","volume":"17","author":"Wang","year":"2025","journal-title":"J Thorac Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3201\/eid2009.131668","article-title":"Pneumocystis jirovecii pneumonia in patients with or without AIDS, France","volume":"20","author":"Roux","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cmi.2023.04.015","article-title":"How to diagnose and treat a patient without human immunodeficiency virus infection having pneumocystis jirovecii pneumonia?","volume":"29","author":"Hansel","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3201\/eid3009.240615","article-title":"Non-HIV immunocompetent patient with COVID-19 and severe pneumocystis jirovecii pneumonia co-infection","volume":"30","author":"Yu","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.chest.2022.08.001","article-title":"Inhaled nitric oxide vs Epoprostenol during acute respiratory failure: an observational target trial emulation","volume":"162","author":"Bosch","year":"2022","journal-title":"Chest"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/1817-1737.41914","article-title":"Role of nitric oxide in management of acute respiratory distress syndrome","volume":"3","author":"Akmal","year":"2008","journal-title":"Ann Thorac Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1053\/j.jvca.2020.09.137","article-title":"Nitric oxide ventilation improves recirculation and right ventricular function during Veno-venous extracorporeal membrane oxygenation in a COVID-19 patient","volume":"35","author":"Heuts","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00134-005-2675-4","article-title":"Inhaled nitric oxide therapy in adults: European expert recommendations","volume":"31","author":"Germann","year":"2005","journal-title":"Intensive Care Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1371183","DOI":"10.3389\/fmed.2024.1371183","article-title":"Case report: inhaled nitric oxide rescued a hypoxemia patient caused by dermatomyositis complicated with interstitial pneumonia","volume":"11","author":"Wu","year":"2024","journal-title":"Front Med (Lausanne)"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1808578\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:08:45Z","timestamp":1779430125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1808578\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":24,"alternative-id":["10.3389\/fmed.2026.1808578"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1808578","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"article-number":"1808578"}}